Literature DB >> 25305352

Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.

Angeline A Giangreco1, Shweta Dambal1, Dennis Wagner2, Theodorus Van der Kwast3, Reinhold Vieth2, Gail S Prins4, Larisa Nonn5.   

Abstract

Previous work on vitamin D in the prostate has focused on the prostatic epithelium, from which prostate cancer arises. Prostatic epithelial cells are surrounded by stroma, which has well-established regulatory control over epithelial proliferation, differentiation, and the inflammatory response. Here we examined the regulation of vitamin D-related genes and inflammatory genes by 1α,25-dihydroxyvitamin D3 (1,25(OH)2D) in laser-capture microdissected prostate tissue from a vitamin D3 clinical trial and in an in vitro model that facilitates stromal-epithelial crosstalk. Analysis of the trial tissues showed that VDR was present in both cell types, whereas expression of the hydroxylases was the highest in the epithelium. Examination of gene expression by prostatic (1,25(OH)2D) concentrations showed that VDR was significantly lower in prostate tissues with the highest concentration of 1,25(OH)2D, and down-regulation of VDR by 1,25(OH) 2D was confirmed in the primary cell cultures. Analysis of inflammatory genes in the patient tissues revealed that IL-6 expression was the highest in the prostate stroma while PTGS2 (COX2) levels were lowest in the prostate cancer tissues from men in the highest tertile of prostatic 1,25(OH)2D. In vitro, TNF-α, IL-6 and IL-8 were suppressed by 1,25 (OH)2D in the primary epithelial cells, whereas TNF-α and PTGS2 were suppressed by 1,25(OH) 2D in the stromal cells. Importantly, the ability of 1,25(OH)2D to alter pro-inflammatory-induced changes in epithelial cell growth were dependent on the presence of the stromal cells. In summary, whereas both stromal and epithelial cells of the prostate express VDR and can presumably respond to 1,25(OH)2D, the prostatic epithelium appears to be the main producer of 1,25(OH)2D. Further, while the prostate epithelium was more responsive to the anti-inflammatory activity of 1,25 (OH)2D than stromal cells, stroma-epithelial crosstalk enhanced the phenotypic effects of 1,25(OH)2D and the inflammatory process in the prostate gland.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Prostate epithelium; Prostate stroma; Vitamin D

Mesh:

Substances:

Year:  2014        PMID: 25305352      PMCID: PMC4361379          DOI: 10.1016/j.jsbmb.2014.10.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  49 in total

1.  Systematic characterisation of the rat and human CYP24A1 promoter.

Authors:  R Kumar; D N Iachini; P M Neilsen; J Kaplan; J Michalakas; P H Anderson; B K May; H A Morris; D F Callen
Journal:  Mol Cell Endocrinol       Date:  2010-05-05       Impact factor: 4.102

Review 2.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

3.  Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

Authors:  Emily A Ricke; Karin Williams; Yi-Fen Lee; Suzana Couto; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; William A Ricke
Journal:  Carcinogenesis       Date:  2012-04-25       Impact factor: 4.944

Review 4.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

Review 5.  A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations.

Authors:  John J McGrath; Sukanta Saha; Thomas H J Burne; Darryl W Eyles
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-02       Impact factor: 4.292

6.  Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH)D concentrations in a sample of young Canadian adults of different ancestry.

Authors:  Agnes Gozdzik; Justin Zhu; Betty Y-L Wong; Lei Fu; David E C Cole; Esteban J Parra
Journal:  J Steroid Biochem Mol Biol       Date:  2011-06-12       Impact factor: 4.292

Review 7.  Prostate inflammation and its potential impact on prostate cancer: a current review.

Authors:  Jessica Haverkamp; Bridget Charbonneau; Timothy L Ratliff
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

8.  Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

Authors:  D M Peehl; R J Skowronski; G K Leung; S T Wong; T A Stamey; D Feldman
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

9.  mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials.

Authors:  Larisa Nonn; Avani Vaishnav; Lindsay Gallagher; Peter H Gann
Journal:  Exp Mol Pathol       Date:  2009-10-27       Impact factor: 3.362

Review 10.  Immune surveillance: a balance between protumor and antitumor immunity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Genet Dev       Date:  2008-03-04       Impact factor: 5.578

View more
  17 in total

1.  microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.

Authors:  Shweta Dambal; Angeline A Giangreco; Andres M Acosta; Andrew Fairchild; Zachary Richards; Ryan Deaton; Dennis Wagner; Reinhold Vieth; Peter H Gann; Andre Kajdacsy-Balla; Theodorus Van der Kwast; Larisa Nonn
Journal:  J Steroid Biochem Mol Biol       Date:  2017-01-12       Impact factor: 4.292

2.  Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis.

Authors:  Giovanni Lugli; Yachana Kataria; Zachary Richards; Peter Gann; Xiaofeng Zhou; Larisa Nonn
Journal:  J Vis Exp       Date:  2015-11-26       Impact factor: 1.355

3.  Vitamin D regulates prostate cell metabolism via genomic and non-genomic mitochondrial redox-dependent mechanisms.

Authors:  Chuck C Blajszczak; Larisa Nonn
Journal:  J Steroid Biochem Mol Biol       Date:  2019-09-28       Impact factor: 4.292

4.  Prostatic compensation of the vitamin D axis in African American men.

Authors:  Zachary Richards; Ken Batai; Rachael Farhat; Ebony Shah; Andrew Makowski; Peter H Gann; Rick Kittles; Larisa Nonn
Journal:  JCI Insight       Date:  2017-01-26

Review 5.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China.

Authors:  Lei Li; Feifei Shang; Weihui Zhang; Canhong Zhang; Junshan Li; Changhui Wang; Lin Wei
Journal:  Tumour Biol       Date:  2015-01-24

Review 7.  Nutrition, inflammation and cancer.

Authors:  Laurence Zitvogel; Federico Pietrocola; Guido Kroemer
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 8.  Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans.

Authors:  Ken Batai; Adam B Murphy; Larisa Nonn; Rick A Kittles
Journal:  Front Immunol       Date:  2016-02-22       Impact factor: 7.561

9.  What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMJ Open       Date:  2018-01-13       Impact factor: 2.692

10.  Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids.

Authors:  Kenji Unno; Meejeon Roh; Young A Yoo; Yousef Al-Shraideh; Lu Wang; Larisa Nonn; Sarki A Abdulkadir
Journal:  Oncotarget       Date:  2017-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.